Terumo Establishes Corporate Venture Capital Organization

August 9, 2024—Terumo Corporation recently announced that it has established Terumo Ventures, a Corporate Venture Capital (CVC) organization responsible for leading the group’s venture investments as a department within Terumo Americas Holding, Inc.

According to the company, Terumo Ventures will operate in global innovation hubs around the world, such as Massachusetts and California in the United States. It will invest $75 million during the next 5 years in early-stage companies, primarily in the fields of cardiovascular disease treatment, chronic disease treatment, and digital technologies.

The CVC initiative will enable Terumo to enhance its access to innovative technologies and business ideas from start-ups, promote open innovation, and pursue synergies with its internal R&D efforts, stated the company.

Terumo noted that since 2013, it has been building relationships with medtech start-ups by investing in venture capital funds in the United States and China.

With the establishment of the CVC, Terumo will identify, evaluate, and execute venture investments, while accelerating the speed of acquiring new technologies and developing a robust M&A target pipeline for future growth. Terumo will continue to innovate through a combination of internal development and partnerships with external parties, stated the company in the press release.